EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrating Environmental Exposures, Epigenetic Programming and Nanotechnology for Chronic Disease Prevention in the One Health Era

Priscila Souza Thomé Gonçalves, Bianca Pizzorno Backx

International Journal of Environmental Medicine · 2026

DOI: 10.3390/ijem1030016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Environmental Medicine, 2026. Verfasst von Priscila Souza Thomé Gonçalves und 1 weiteren Autor:innen. Die Arbeit nennt 188 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic diseases rank among the major challenges for global public health, and interactions between environmental exposures, biological susceptibility, and developmental processes increasingly shape their severity. Evidence indicates that exposure to air pollutants, heavy metals, pesticides, microplastics, and endocrine-disrupting chemicals can promote oxidative stress, chronic inflammation, mitochondrial dysfunction, endocrine dysregulation, and epigenetic alterations, particularly during critical developmental periods. Through mechanisms consistent with the Developmental Origins of Health and Disease (DOHaD) framework, these disruptions can contribute to long-term susceptibility to cardiovascular, metabolic, respiratory, neurodegenerative, and neoplastic diseases. In this context, nanotechnology offers emerging opportunities for prevention, early detection, monitoring, targeted therapy, and environmental remediation. Nanobiosensors and nanoscale diagnostic platforms can enable the sensitive detection of molecular and epigenetic biomarkers, while nanotechnology-based drug delivery systems can improve therapeutic targeting and controlled release. Concurrently, nanomaterials, magnetic nanocomposites, photocatalytic systems, and green nanotechnologies demonstrate potential to remove or transform environmental contaminants and reduce human exposure. However, the translational maturity of these applications varies substantially, ranging from clinically approved nanomedicines to predominantly preclinical and laboratory-scale approaches, underscoring the need for rigorous safety assessments, regulatory frameworks, and validation under real-world conditions. Overall, integrating nanotechnology with environmental health, epigenetic research, sustainability, and the One Health approach may offer a multidisciplinary pathway toward earlier interventions, reduced exposure, and the prevention of chronic diseases, while simultaneously promoting human, animal, and environmental health.

Förderung

  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro

Zitieren

APA

Gonçalves, P. S. T., & Backx, B. P. (2026). Integrating Environmental Exposures, Epigenetic Programming and Nanotechnology for Chronic Disease Prevention in the One Health Era. International Journal of Environmental Medicine. https://doi.org/10.3390/ijem1030016

Vancouver

Gonçalves PST, Backx BP. Integrating Environmental Exposures, Epigenetic Programming and Nanotechnology for Chronic Disease Prevention in the One Health Era. International Journal of Environmental Medicine. 2026. doi:10.3390/ijem1030016

BibTeX
@article{Gonalves2026,
  author = {Gonçalves, Priscila Souza Thomé and Backx, Bianca Pizzorno},
  title = {Integrating Environmental Exposures, Epigenetic Programming and Nanotechnology for Chronic Disease Prevention in the One Health Era},
  journal = {International Journal of Environmental Medicine},
  year = {2026},
  doi = {10.3390/ijem1030016}
}
Kostenlos starten →